š¬ Current Disease Focus:
Task Progress: 0%
š„ Active Problem Solvers
0
š Experts collaborating globally
ā” Current Task Assignment
š§¬ Genetic Analysis
š Matching experts to specific tasks
š Resource Allocation by Research Phase:
š Data Analysis
š§Ŗ Experimental Design
š¬ Clinical Trials
š Treatment Development
A two-part trial in patients with metastic Ewing's sarcoma. Participants in...
Status
Completed
Location
Arkansas Children's Hospital
Start Date
2016-02-10
Trial ID
NCT02511132
Treatments Being Tested
The clinical trial was a companion study to protocol CL-PTL-119 (A Randomiz...
Status
Completed
Location
University of South Alabama Mitchell Cancer Institute
Start Date
2017-05-31
Trial ID
NCT03073525
Treatments Being Tested
This was a clinical trial for women with ovarian cancer scheduled to have a...
Status
Completed
Location
Florida Cancer Specialists
Start Date
2011-03-08
Trial ID
NCT01309230
Treatments Being Tested
This is a Phase II study of Vigilā¢ autologous tumor cell vaccine integrated...
Status
Completed
Location
Mary Crowley Cancer Research Centers
Start Date
2012-03
Trial ID
NCT01551745
Treatments Being Tested
Preliminary studies with a variety of vaccines suggest target accessibility...
Status
Terminated
Location
Mary Crowley Cancer Research Centers
Start Date
2011-10
Trial ID
NCT01453361
Treatments Being Tested
This is an open label Pilot study to evaluate the combination of Vigilā¢ and...
Status
Completed
Location
Texas Oncology P.A., Texas Cancer Center
Start Date
2015-10
Trial ID
NCT02574533
Treatments Being Tested
Autologous Vigilā¢ vaccine expresses rhGMCSF and bi-shRNAfurin from the Vigi...
Status
Completed
Location
Florida Cancer Specialists
Start Date
2009-12
Trial ID
NCT01061840
This is an open label phase 2 study to evaluate the combination of Vigilā¢ a...
Status
Withdrawn
Location
Texas Oncology, P.A., Texas Cancer Center
Start Date
2016-03
Trial ID
NCT02639234
This is a Phase II study of Vigilā¢ autologous tumor cell vaccine integrated...
Status
Completed
Location
Mary Crowley Cancer Research Centers
Start Date
2013-06
Trial ID
NCT01867086
Treatments Being Tested
Preliminary studies with a variety of vaccines suggest target accessibility...
Status
Terminated
Location
Mary Crowley Cancer Research Centers
Start Date
2012-03
Trial ID
NCT01505166
Treatments Being Tested